Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

被引：0
|
作者：
Ralf W. Dittmann
Esther Cardo
Peter Nagy
Colleen S. Anderson
Ralph Bloomfield
Beatriz Caballero
Nicholas Higgins
Paul Hodgkins
Andrew Lyne
Richard Civil
David Coghill
机构：
[1] University of Heidelberg,Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim
[2] University of the Balearic Islands,Son Llàtzer Hospital and Research Institute on Health Sciences
[3] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,Division of Neuroscience
[4] Shire Development LLC,undefined
[5] Shire Pharmaceutical Development Ltd,undefined
[6] Shire AG,undefined
[7] University of Dundee,undefined
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Atomoxetine; Guanfacine; ADHD Medication; Lisdexamfetamine; Amfetamine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1081 / 1092
页数：11
相关论文
共 50 条
  • [1] Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study
    Dittmann, Ralf W.
    Cardo, Esther
    Nagy, Peter
    Anderson, Colleen S.
    Bloomfield, Ralph
    Caballero, Beatriz
    Higgins, Nicholas
    Hodgkins, Paul
    Lyne, Andrew
    Civil, Richard
    Coghill, David
    CNS DRUGS, 2013, 27 (12) : 1081 - 1092
  • [2] Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
    Ralf W. Dittmann
    Esther Cardo
    Peter Nagy
    Colleen S. Anderson
    Ben Adeyi
    Beatriz Caballero
    Paul Hodgkins
    Richard Civil
    David R. Coghill
    CNS Drugs, 2014, 28 : 1059 - 1069
  • [3] Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
    Dittmann, Ralf W.
    Cardo, Esther
    Nagy, Peter
    Anderson, Colleen S.
    Adeyi, Ben
    Caballero, Beatriz
    Hodgkins, Paul
    Civil, Richard
    Coghill, David R.
    CNS DRUGS, 2014, 28 (11) : 1059 - 1069
  • [4] EFFICACY OF LISDEXAMFETAMINE DIMESYLATE AND ATOMOXETINE IN CHILD AND ADOLESCENT SUBGROUPS FROM A HEAD-TO-HEAD, DOUBLE-BLIND, RANDOMIZED TRIAL IN PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Dittmann, R. W.
    Cardo, E.
    Coghill, D. R.
    Nagy, P.
    Anderson, C. S.
    Adeyi, B.
    Caballero, B.
    Hodgkins, P.
    Civil, R.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [5] A head-to-head, double-blind, randomized, phase 3b trial comparing the efficacy of lisdexamfetamine dimesylate with atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Dittmann, Ralf
    Cardo, Esther
    Coghill, David
    Nagy, Peter
    Adeyi, Ben
    Anderson, Colleen
    Caballero, Beatriz
    Higgins, Nicholas
    Hodgkins, Paul
    Civil, Richard
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S222 - S223
  • [6] Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
    Peter Nagy
    Alexander Häge
    David R. Coghill
    Beatriz Caballero
    Ben Adeyi
    Colleen S. Anderson
    Vanja Sikirica
    Esther Cardo
    European Child & Adolescent Psychiatry, 2016, 25 : 141 - 149
  • [7] Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
    Nagy, Peter
    Haege, Alexander
    Coghill, David R.
    Caballero, Beatriz
    Adeyi, Ben
    Anderson, Colleen S.
    Sikirica, Vanja
    Cardo, Esther
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2016, 25 (02) : 141 - 149
  • [8] Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Adler, Lenard A.
    Goodman, David W.
    Kollins, Scott H.
    Weisler, Richard H.
    Krishnan, Suma
    Zhang, Yuxin
    Biederman, Joseph
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (09) : 1364 - +
  • [9] Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Childress, Ann C.
    Cutler, Andrew J.
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (04): : 395 - 405
  • [10] Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Goodman, D.
    Adler, L.
    Kollins, S. H.
    Weisler, R.
    Krishnan, S.
    Zhang, Y.
    Biederman, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 292 - 293
12345